Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease

Muscle-specific kinase (MuSK) Myasthenia Gravis (MG) represents a prototypical antibody-mediated disease characterized by predominantly focal muscle weakness (neck, facial, and bulbar muscles) and fatigability. The pathogenic antibodies mostly belong to the immunoglobulin subclass (Ig)G4, a feature...

Descripción completa

Detalles Bibliográficos
Autores principales: Vakrakou, Aigli G., Karachaliou, Eleni, Chroni, Elisabeth, Zouvelou, Vasiliki, Tzanetakos, Dimitrios, Salakou, Stavroula, Papadopoulou, Marianna, Tzartos, Socrates, Voumvourakis, Konstantinos, Kilidireas, Constantinos, Giannopoulos, Sotirios, Tsivgoulis, Georgios, Tzartos, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410455/
https://www.ncbi.nlm.nih.gov/pubmed/37564637
http://dx.doi.org/10.3389/fimmu.2023.1212757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410455/
https://www.ncbi.nlm.nih.gov/pubmed/37564637
http://dx.doi.org/10.3389/fimmu.2023.1212757

Ejemplares similares